Gouty arthritis (NICE TA 281 - terminated appraisal)
NICE TA281 - Canakinumab for treating gouty arthritis attacks and reducing the frequency of subsequent attacks (terminated appraisal)
The NICE appraisal was suspended as the manufacturer had not engaged with the NICE review process.
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria